`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`SANDOZ INC.,
`APOTEX INC., APOTEX CORP.,
`EMCURE PHARMACEUTICALS LTD.,
`HERITAGE PHARMA LABS INC.,
`HERITAGE PHARMACEUTICALS INC.,
`GLENMARK PHARMACEUTICALS, INC., USA,
`GLENMARK HOLDING SA,
`GLENMARK PHARMACEUTICALS, LTD.,
`MYLAN LABORATORIES LIMITED,
`TEVA PHARMACEUTICALS USA, INC.
`FRESENIUS KABI USA, LLC, and WOCKHARDT BIO AG,
`
`Petitioners
`
`v .
`
`ELI LILLY AND COMPANY,
`
`Patent Owner.
`
`Case IPR2016-003181
`U.S. Patent 7,772,209
`
`
`
`
`
`
`
`
`
`
`JOINT STIPULATION REGARDING THE DEPOSITION OF
`DR. STEVEN H. ZEISEL, M.D., Ph.D.
`
`
`1 Cases IPR2016-01429, IPR2016-01393, and IPR2016-01340 have been joined
`with the instant proceeding.
`
`
`
`Petitioner Sandoz Inc. (“Sandoz”) and Patent Owner Eli Lilly & Co.
`
`(“Lilly”) have reached an agreement in order to reduce discovery related to the
`
`deposition of Dr. Steven H. Zeisel, M.D., Ph.D., and hereby stipulate and agree
`
`as follows:
`
`1.
`
`Dr. Steven H. Zeisel, M.D., Ph.D. submitted an expert declaration in
`
`the above-captioned inter partes review on September 30, 2016. (Ex. 2118,
`
`Zeisel Decl.)
`
`2.
`
`On September 30, 2016, Dr. Zeisel submitted a substantively
`
`identical expert declaration in Neptune Generics, LLC v. Eli Lilly and Co., Inc.,
`
`IPR2016-00237 and Neptune Generics, LLC v. Eli Lilly and Co., Inc., IPR2016-
`
`00240 (hereinafter, “Neptune IPRs”). (IPR2016-00237, Ex. 2118, Zeisel Decl.;
`
`IPR2016-00240, Ex. 2118, Zeisel Decl.)
`
`3.
`
`On November 14, 2016, Sandoz timely noticed the deposition of Dr.
`
`Steven H. Zeisel, M.D., Ph.D., in the above-captioned inter partes review for
`
`Wednesday, November 30, 2016. (Paper No. 45, Dep. Notice.)
`
`4.
`
`Dr. Steven H. Zeisel was deposed on November 22, 2016 in the
`
`Neptune IPRs. (IPR2016-00237, Paper No. 43, Dep. Notice; IPR2016-00240,
`
`Paper No. 42, Dep. Notice.)
`
`
`
`
`
`5.
`
`Lilly agrees that Sandoz may file the transcript of Dr. Zeisel’s
`
`deposition testimony in the Neptune IPRs as an exhibit in the above-captioned
`
`IPR and that Sandoz may rely on that transcript.
`
`6.
`
`Sandoz agrees to withdraw the deposition notice for Dr. Zeisel in
`
`IPR2016-00318 and forgo a separate deposition of Dr. Zeisel in IPR2016-00318.
`
`7.
`
`Sandoz will submit an updated Exhibit List with its Reply Brief,
`
`which will list Exhibits referenced in Dr. Zeisel’s deposition in the Neptune
`
`IPRs. To the extent the numbering of any such exhibits conflicts with numbering
`
`already used for different exhibits in the Sandoz proceeding, Sandoz’s updated
`
`Exhibit List will include cross-references as appropriate.
`
`
`
`Dated: December 6, 2016
`
`/s/ Dov P. Grossman (with permission)
`Adam L. Perlman
`Dov P. Grossman (Reg. No. 72,525)
`David M. Krinsky (Reg. No. 72,339)
`Williams & Connolly LLP
`725 Twelfth St. NW
`Washington DC 20005
`
`James P. Leeds (Reg. No. 35,241)
`John C. Demeter (Reg. No. 30,167)
`Eli Lilly and Company
`Lilly Corporate Center
`Indianapolis, IN 46285
`Counsel for Eli Lilly & Co.
`
`
`
`
`Respectfully submitted,
`
`/s/ Ralph J. Gabric
`Ralph J. Gabric (Reg. No. 34,167)
`Laura L. Lydigsen
`Bryan T. Richardson, Ph.D. (Reg. No.
`70,572)
`Joshua H. James (Reg. No. 72,568)
`Brinks Gilson & Lione
`NBC Tower – Suite 3600
`455 N. Cityfront Plaza Dr.
`Chicago, Illinois 60611
`
`Counsel for Sandoz Inc.
`
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that true and correct copies of the foregoing document was
`served on December 6, 2016 via email to the following individuals at the email
`addresses below.
`
`Dov P. Grossman (Reg. No. 72,525)
`Williams & Connolly LLP
`725 Twelfth St. NW
`Washington DC 20005
`Direct Phone: 202-434-5812
`Facsimile: 202-434-5029
`dgrossman@wc.com
`
`Williams & Connolly LLP
`725 Twelfth St. NW
`Washington DC 20005
`Direct Phone: 202-434-5338
`Facsimile: 202-480-8302
`dkrinsky@wc.com
`
`Adam L. Perlman
`Williams & Connolly LLP
`725 Twelfth St. NW
`Washington DC 20005
`Direct Phone: 202-434-5244
`aperlman@wc.com
`
`James P. Leeds (Reg. No. 35,241)
`Eli Lilly and Company
`Lilly Corporate Center
`Indianapolis, IN 46285
`Direct Phone: 317-276-1667
`Facsimile: 317-277-6534
`leeds_james@lilly.com
`
`John C. Demeter (Reg. No. 30,167)
`Eli Lilly and Company
`Lilly Corporate Center
`
`
`
`
`
`Indianapolis, IN 46285
`Direct Phone: 317-276-3785
`Facsimile: 317-276-3861
`demeter_john_c@lilly.com
`
`
`
`
`
`/s/ Ralph J. Gabric
`Ralph J. Gabric (Reg. No. 34,167)
`Laura L. Lydigsen
`Bryan T. Richardson, Ph.D. (Reg. No.
`70,572)
`Joshua H. James (Reg. No. 72,568)
`Brinks Gilson & Lione
`NBC Tower – Suite 3600
`455 N. Cityfront Plaza Dr.
`Chicago, Illinois 60611
`
`
`
`
`
`Dated: December 6, 2016
`
`
`
`
`
`
`